We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals

43 hedge funds and large institutions have $17.1M invested in Actinium Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 5

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

130% more capital inflows, than outflows

Capital inflows: $2.4M | Capital outflows: $1.04M

16% more funds holding

Funds holding: 37 → 43 (+6)

1.02% more ownership

Funds ownership: 8.56% → 9.57% (+1%)

7% more call options, than puts

Call options by funds: $4.62M | Put options by funds: $4.32M

Holders
43
Holders Change
+6
Holders Change %
+16.22%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
13
Reduced
5
Closed
5
Calls
$4.62​M
Puts
$4.32​M
Net Calls
+$302​K
Net Calls Change
-⁠$1.82​M

ATNM Hedge Fund Activity: Q3 2021 in Review

43 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q3 2021, worth a combined $17.1M — up 25% from $13.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ATNM positions and 5 closed out — a net gain of 7 holders — while 13 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $327K. The largest seller was First Trust Advisors, exiting entirely with an estimated $406K sold.

  • 43 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q3 2021, up from 37 in Q2 2021.
  • Funds reported $17.1M of Actinium Pharmaceuticals stock for Q3 2021, up 25% quarter-over-quarter.
  • 12 funds opened new Actinium Pharmaceuticals positions in Q3 2021 and 5 closed out, a net change of +7 holders.
  • The largest Actinium Pharmaceuticals buyer in Q3 2021 was Vanguard Group, an estimated $327K added.
  • The largest Actinium Pharmaceuticals seller in Q3 2021 was First Trust Advisors, an estimated $406K sold.

Based on aggregated 13F filings for Q3 2021.